The Vbeam Pro device is the only vascular laser FDA-cleared for use in pediatric patients and combines an advanced 595 nm pulsed dye laser with a 1064 nm Nd:YAG wavelength to offer unmatched precision ...
WAYLAND, Mass., Sept. 26, 2018 /PRNewswire/ -- Candela Corporation, a leading global manufacturer of energy-based devices, announces it will be partnering with the Vascular Birthmarks Foundation (VBF) ...
MCLEAN, VA / ACCESSWIRE / September 15, 2023 / Dr. Amir Bajoghli and the Skin & Laser Dermatology Center proudly unveil the Candela VBeam Perfecta treatment, the latest generation of pulse dye laser ...
WAYLAND, MA--(Marketwire - 07/19/10) - Candela Corporation, a subsidiary of Syneron Medical Ltd. (NASDAQ:ELOS - News), today announced that it has received registration approval from the Japanese ...
MARLBOROUGH, Mass., April 24, 2025 /PRNewswire/ -- Candela Corporation, a global leader in energy-based medical aesthetics, proudly announced the launch of the Vbeam Pro platform at the 2025 Annual ...
MCLEAN, VA / ACCESSWIRE / September 15, 2023 / Dr. Amir Bajoghli and the Skin & Laser Dermatology Center proudly unveil the Candela VBeam Perfecta treatment, the latest generation of pulse dye laser ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results